Cerdelga
Payments companies reported to CMS as associated with Cerdelga. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Cerdelga, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Cerdelga
These are the largest totals companies reported as associated with Cerdelga. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Kyrieckos Aleck | Albuquerque, NM | Clinical Genetics (M.D.) | $115,371.33 |
| Stuart Ditchek | Brooklyn, NY | General Practice | $110,155.12 |
| Maurizio Ghisoli | Dallas, TX | Pediatric Hematology-Oncology | $101,669.00 |
| Joseph Ray | Galveston, TX | Clinical Genetics (M.D.) | $92,826.98 |
| Ravi Kamath | Fairfax, VA | Diagnostic Radiology | $70,524.92 |
| Neil Nagovski | Miami, FL | Hematology & Oncology | $65,071.94 |
| Linda Spencer | Troy, MI | Nurse Practitioner | $58,607.02 |
| Dmitriy Niyazov | Durham, NC | Clinical Genetics (M.D.) | $45,910.66 |
| Neal Weinreb | Coral Springs, FL | $30,589.52 | |
| Richard Rogers | Greenville, SC | Clinical Genetics (M.D.) | $29,041.15 |
Prescribed Cerdelga?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.